Second line Bladder Cancer Therapies When First Line Treatments Fail

preview_player
Показать описание
Jennifer M. Taylor, MD, MPH, discusses risk-stratification in non-muscle invasive bladder cancer (NMIBC), definitions of treatment failure in this setting, and indicated workup for suspected failure. She then reviews salvage intravesical options under investigation in clinical trials for Bacillus Calmette–Guérin (BCG) unresponsive NMIBC.
  1. Grand Rounds in Urology
  2. Jennifer M. Taylor
  3. non-muscle invasive bladder cancer
  4. NMIBC
  5. BCG
  6. BCG-unresponsive
Рекомендации по теме
Second line Bladder 0:19:31

Second line Bladder Cancer Therapies When First Line Treatments Fail

Evaluating Second-Line Treatment 0:01:36

Evaluating Second-Line Treatment Options in Bladder Cancer

Exploring Perioperative Therapies 0:04:04

Exploring Perioperative Therapies and Second-Line Treatments in Bladder Cancer

Dr. Petrylak on 0:01:41

Dr. Petrylak on Immunotherapy for Second-line Treatment in Bladder Cancer

KEYNOTE-045 – pembrolizumab 0:01:09

KEYNOTE-045 – pembrolizumab as second-line treatment in urothelial carcinoma

Immunotherapy in Second-Line 0:06:35

Immunotherapy in Second-Line Advanced Bladder Cancer

Dr. James L. 0:01:30

Dr. James L. Gulley on Treatment Beyond the Second Line in Bladder Cancer

Real-world outcomes of 0:04:06

Real-world outcomes of second-line chemotherapy on advanced biliary tract and gallbladder cancers

Dr. Friedlander on 0:01:48

Dr. Friedlander on Checkpoint Inhibitors in Second-Line Bladder Cancer Treatment

AUA2021 State-Of-The-Art Lecture 0:16:20

AUA2021 State-Of-The-Art Lecture First & Second Line Therapy In Advanced & Metastatic Bladde...

What to do 0:01:00

What to do in 2nd Line for bladder cancer? | Dr. Rana McKay | Oncology Brothers #oncology #cancer

Choosing Second-Line Therapy 0:01:04

Choosing Second-Line Therapy for Patients With Urothelial Carcinoma

Dr. Plimack on 0:01:14

Dr. Plimack on Second-Line Checkpoint Inhibitors in Bladder Cancer

Advanced Bladder Cancer: 0:27:17

Advanced Bladder Cancer: Chemotherapy & Immunotherapy

Systemic Treatment of 0:44:45

Systemic Treatment of Bladder Cancer: The Benefits of Clinical Pathways

Evidence and Insights 1:09:47

Evidence and Insights on Innovative Treatment for Bladder Cancer

Living with kidney 0:41:25

Living with kidney cancer Webinars - Second line treatment for metastatic disease

Highlighting Clinical Trials: 0:21:20

Highlighting Clinical Trials: Advanced/Metastatic Bladder Cancer | Part II

Updates on Immunotherapy 0:03:32

Updates on Immunotherapy for Bladder Cancer

Immunotherapeutic Agents in 0:25:33

Immunotherapeutic Agents in Metastatic Bladder Cancer

New emerging treatment 0:14:16

New emerging treatment options and targeted therapies for bladder cancer

Second-Line Therapy for 0:02:16

Second-Line Therapy for Metastatic Renal Cell Cancer

Immunotherapy for Muscle 0:19:21

Immunotherapy for Muscle Invasive Bladder Cancer

Dr. Garcia on 0:01:28

Dr. Garcia on Selecting Second-line Immunotherapy in Bladder Cancer

Комментарии
Автор

Thank you for info. I have agressive T1, 6 BCG treatments, Cystoscopy and next week Biopsy. At least now I know there are other options. With Covid it is impossible to talk to doctors and get all this very important info. Again thanks.

terrywilding